Showing 1201-1210 of 1616 results for "".
- Sight Sciences Raises $56M to Lead the Development of MIGS Market and Procedure-Based Dry Eye Markethttps://modernod.com/news/sight-sciences-raises-56m-to-lead-the-development-of-migs-market-and-procedure-based-dry-eye-market/2476848/Sight Sciences announced the closing of $31 million in Series D Preferred Stock financing. MidCap Financial and Sight Sciences entered into a $25 million debt facility earlier in 2019. The $56 million
- Aggressive Steroid Therapy Improves Visual Outcomes in Vogt-Koyanagi-Harada Diseasehttps://modernod.com/news/aggressive-steroid-therapy-improves-visual-outcomes-in-vogt-koyanagi-harada-disease/2480135/Aggressive treatment beginning with pulsed intravenous corticosteroids appears to improve visual outcomes of new-onset acute Vogt-Koyanagi-Harada (VKH) disease, researchers from Japan report, according to a report in Medscape. VKH d
- Eye Foundation of America Hosts Fundraising Galahttps://modernod.com/news/eye-foundation-of-america-hosts-fundraising-gala/2482734/On April 12, the Eye Foundation of America is hosting a Spring fundraiser gala in New Rochelle, New York. Under the leadership of Surendra Sharma, MD and Rachana Shukla, MD, the group hopes to raise funds to help support a new state-of-the-art green hospital in India, as well
- Oculis and Euretina Announce Winner of Inaugural Ramin Tadayoni Awardhttps://modernod.com/news/oculis-and-euretina-announce-winner-of-inaugural-ramin-tadayoni-award/2482449/Oculis, in partnership with Euretina, has announced the first recipient of the Ramin Tadayoni Award: Dr. Andrea Govetto, MD, PhD. The award honors the memory of Oculis' late Chief Scientific Officer and renowned retina specialist, Professor Ramin Tadayoni, MD, who passed away unexpectedly ear
- Inaugural Eyecelerator Innovation Award Presented to Regeneron Executiveshttps://modernod.com/news/inaugural-eyecelerator-innovation-award-presented-to-regeneron-executives/2482404/Leonard Schleifer, MD, PhD, and George Yancopoulos, MD, PhD, of Regeneron Pharmaceuticals were awarded the first Eyecelerator Innovation Award. "This year's Eyecelerator Innovation Award honors the remarkable physician-led, science-dr
- NEI Director Highlights Metabolomics as an Approach to Understanding Glaucomahttps://modernod.com/news/nei-director-highlights-metabolomics-as-an-approach-to-understanding-glaucoma/2481982/The National Eye Institute (NEI) announced that NEI Director Michael F. Chiang, MD, featured recent research by NEI grantee Louis Pasquale, MD, in a National Institute of Health Director’s Blog post. Dr. Pasquale in collaboration with Jae Hee Kang, ScD, and Oana Zeleznik, PhD, explored 369
- EyePoint Pharmaceuticals Forms Executive Scientific Advisory Boardhttps://modernod.com/news/eyepoint-pharmaceuticals-forms-executive-scientific-advisory-board/2479426/EyePoint Pharmaceuticals announced the formation of its Executive Scientific Advisory Board (SAB), chaired by Carl Regillo MD, FACS, Chief of the Retina Service at Wills Eye Hospital. Other members of the SAB include Sophie J. Bakri, MD, Mayo Clinic; Caroline R. B
- Noveome Biotherapeutics Announces Preliminary Results of its Phase 1 Trial Evaluating Intranasal Delivery of ST266 In Glaucoma Suspect Patientshttps://modernod.com/news/noveome-biotherapeutics-announces-preliminary-results-of-its-phase-1-trial-evaluating-intranasal-delivery-of-st266-in-glaucoma-suspect-patients/2479275/Noveome Biotherapeutics announced preliminary results of a phase 1 open label clinical trial to establish the safety of ST266 when delivered intranasally in glaucoma suspect patients. The trial was conducted at the University of Pennsylvania by Ahmara Ross, MD, PhD, and Kenneth Shindler, MD, PhD,
- Health Care Experts Named to Biden’s COVID-19 Advisory Boardhttps://modernod.com/news/health-care-experts-named-to-bidens-covid-19-advisory-board/2478511/Former U.S. Surgeon General Vivek Murthy, MD, and former FDA Commissioner David Kessler, MD, will be among the public health leaders guiding the transition team for President-elect Joe Biden regarding COVID-19, according to a FierceHealthcare
- NIH Selects Dr. Michael Chiang as Director of the National Eye Institutehttps://modernod.com/news/nih-selects-dr-michael-chiang-as-director-of-the-national-eye-institute/2478074/National Institutes of Health Director Francis S. Collins, MD, PhD, has chosen Michael F. Chiang, MD, as director of NIH’s National Eye Institute (NEI). A practicing ophthalmologist, Dr. Chiang is currently the Knowles Professor of Ophthalmology & Medical Informatics and Clinical Epide